Podcasts about UnitedHealth Group

Negli ultimi anni negli Stati Uniti - il riassunto lo fa egregiamente il giornalista Ezra Klein in un tweet - ci sono stati stati:  - un piano, sventato dall'Fbi, per rapire Gretchen Whitmer, attuale governatrice del Michigan. - L'assalto al Campidoglio del 6 gennaio 2021. - Il tentativo di sequestro di Nancy Pelosi, già speaker della Camera dei Rappresentanti degli Stati Uniti, e l'aggressione a suo marito Paul. - I molteplici tentativi di assassinio di Donald Trump.  - L'assassinio della speaker della Camera dei Rappresentanti del Minnesota, Melissa Hortman, e di suo marito.  - Il ferimento del senatore John Hoffman e di sua moglie.  - L'assassinio da parte di Luigi Mangione di Brian Thompson, amministratore delegato di UnitedHealth Group. - L'assassinio di Charlie Kirk, avvenuto mercoledì 10 settembre, mentre era in un campus in Utah. 

This Day in Legal History: Ford Grants Nixon PardonOn September 8, 1974, President Gerald R. Ford granted a full and unconditional pardon to former President Richard M. Nixon for any crimes he may have committed while in office, specifically those related to the Watergate scandal. The announcement came just one month after Nixon resigned in disgrace, becoming the first U.S. president to do so. Ford, who had only recently assumed the presidency, delivered the pardon via a televised address, explaining that he hoped to heal the nation's wounds and end the "long national nightmare." The decision was met with swift and widespread controversy.Critics accused Ford of striking a backroom deal with Nixon—trading the presidency for a guarantee of legal immunity. The move damaged Ford's credibility and likely contributed to his loss in the 1976 presidential election. Supporters, however, argued that the pardon was necessary to move the country forward and prevent a divisive, prolonged legal spectacle. Legally, the pardon was grounded in Article II, Section 2 of the U.S. Constitution, which grants the president broad clemency powers for federal offenses. Importantly, Nixon had not been formally charged at the time of the pardon, making it a preemptive act.The pardon set a precedent for the scope of presidential pardon powers, later cited in legal arguments involving other controversial figures. It also fueled lasting debates about executive accountability and the limits of legal immunity for high-ranking officials. Public opinion at the time was largely against the decision, but historical reassessment has yielded more nuanced views. Ford later received the Profile in Courage Award in 2001 for the pardon, which some historians came to see as a politically costly but morally principled decision. The moment remains a defining one in the legal and political legacy of both Nixon and Ford.Luigi Mangione, accused of murdering UnitedHealth Group executive Brian Thompson, argued in a court filing that federal prosecutors unfairly prejudiced potential jurors by linking him to a separate mass shooting. Prosecutors had previously claimed Mangione inspired Shane Tamura, who killed four people and himself at the offices of Blackstone and the NFL. Mangione's attorneys countered that there is no evidence Tamura was influenced by either Mangione or his anti-health-insurance-industry writings. They accused the government of deliberately trying to bias jurors and undermine Mangione's right to a fair trial.The government cited Tamura in response to Mangione's request for more details on what prosecutors might argue during a potential capital sentencing phase. Prosecutors claimed that Mangione's alleged ability to inspire vigilante violence demonstrates his dangerousness and supports their pursuit of the death penalty. However, Mangione rejected any link to Tamura and called the connection politically motivated. His legal team reiterated its demand for more information on the government's death penalty theory. U.S. District Judge Margaret Garnett will determine whether the prosecution must share additional details at this stage.Luigi Mangione Says Linking Him to Blackstone Killer Biases JuryThe Trump administration has announced plans to deport Kilmar Abrego, a Salvadoran migrant at the center of a high-profile immigration case, to Eswatini, a country in southern Africa with which he has no ties. Abrego is currently detained in Virginia and previously faced deportation to Uganda, but the destination was changed after he claimed fear of persecution there. A Department of Homeland Security official dismissed his claims, citing that he has alleged fear of persecution in over 20 countries.Abrego was initially deported to El Salvador in March despite a court order blocking the move, prompting criticism of the administration's handling of his case. He was later returned to the U.S. in June to face federal charges of transporting undocumented migrants, to which he has pleaded not guilty. His attorneys argue that the prosecution is retaliatory and aimed at coercing a guilty plea. They also revealed that the government offered to send him to Costa Rica if he accepted a plea deal, or to Uganda if he refused.Abrego, who had been living in Maryland with his American wife and children, has become a symbol in the broader debate over immigration enforcement. The administration previously used deportation flights to Eswatini for people labeled too dangerous for their home countries to accept, raising further concerns about Abrego's treatment.Trump administration says migrant Abrego could be deported to Eswatini | ReutersThe Trump administration has officially ended its legal defense of a rule, created under President Biden, that banned employee noncompete agreements. These agreements prevent workers from joining competing businesses or starting their own in the same industry. On Friday, the Justice Department moved to dismiss two appeals in federal courts that challenged rulings striking down the 2024 Federal Trade Commission (FTC) rule. The decision was widely expected after Trump-appointed FTC Chair Andrew Ferguson, a critic of the rule, indicated earlier this year that the agency was reviewing its legality.The dropped appeals mean courts will not rule on whether the FTC has the authority to implement broad nationwide bans under its antitrust mandate. The original FTC rule had cited evidence that over 20% of U.S. workers are bound by noncompete clauses, which it argued restrict worker mobility and depress wages. However, Ferguson and other Republicans maintain that the FTC lacks the rulemaking power to impose such sweeping bans.The legal challenges were brought by a marketing firm, a real estate developer, the U.S. Chamber of Commerce, and other business groups. During Trump's first term, his administration held that although some noncompete clauses might be illegal, the agreements as a whole were not. Meanwhile, the FTC announced a new enforcement action against a major pet cremation company, accusing it of using unlawful noncompetes, including for low-wage workers.Trump administration drops defense of ban on employee 'noncompete' agreements | ReutersThe Trump administration is preparing backup plans to continue imposing tariffs if the Supreme Court rejects its current legal basis for doing so. After losing in lower courts, Trump is asking the Supreme Court to uphold his use of the International Emergency Economic Powers Act (IEEPA), a 1970s national security law that appellate judges ruled does not authorize tariffs. In the meantime, White House officials have been quietly exploring other legal tools for months, anticipating potential judicial pushback.Two key alternatives under consideration are Section 232 of the Trade Expansion Act of 1962 and Section 301 of the Trade Act of 1974. Section 232 allows the president to raise tariffs if certain imports are found to threaten national security—many of Trump's existing tariffs fall under this provision and wouldn't be directly affected by the IEEPA ruling. Section 301 permits the U.S. trade representative, under presidential direction, to take action in response to unfair trade practices. However, neither law offers the speed and flexibility that IEEPA provided, and each comes with legal and logistical hurdles.Trump's legal team and advisers remain confident that the Supreme Court, with a conservative majority that includes three of his appointees, might still side with him. But regardless of the legal outcome, the administration is determined to maintain a public and political case for Trump's tariff powers, framing them as essential to national security and foreign policy goals. These legal uncertainties are complicating U.S. trade negotiations, as foreign governments remain cautious and unconvinced that the court case will significantly shift the U.S. position.The White House is exploring how to keep Trump's tariffs if the Supreme Court strikes them down This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Jaké tituly prodávaly a nakupovaly investorské hvězdy? Teď už to víme. Velké americké fondy musely před dvěma týdny podle zákona nahlásit změny ve svých portfoliích. Zatřásli jimi - kvůli turbulentní celní politice amerického prezidenta Donalda Trumpa - docela dost. Po výplachu trhů následoval růst.„Byli aktivní spíše nadprůměrně a spíše dokupovali, než otevírali nové pozice. Ale i to otevírání nových pozic tam bylo,“ hodnotí změny v portfoliích akciová analytička Anna Píchová z One Family Office, která spravuje majetek společnosti Havel & Partners.Nejnakupovanějšími tituly byly akcie konglomerátu Berkshire Hathaway Warrena Buffetta, internetového obchodu Amazon a americké zdravotní pojišťovny United Health Group. Přikupovaly se i velké technologické firmy jako Amazon, Alphabet, Meta, Nvidia a Apple. Naopak akcie Microsoftu investoři spíše prodávali.*****Ve vatě. Podcast novinářky Markéty Bidrmanové. Poslechněte si konkrétní rady investorů a odborníků na téma investic, inflace, úvěrů a hypoték. Finanční „kápézetka“ pro všechny, kterým nejsou peníze ukradené.Vychází každý čtvrtek. Poslouchejte na Seznam Zprávách, Podcasty.cz nebo ve všech podcastových aplikacích.V podcastu vysvětlujeme základní finanční pojmy a principy, nejde ale o investiční poradenství.O čem byste chtěli poslouchat příště? Co máme zlepšit? A co naopak určitě neměnit? Vaše připomínky, tipy i výtky uvítáme na adrese audio@sz.cz.

"I think my media roles have resulted in trust, but that's not why I got into it. I got into it because what an incredible platform to have... to educate the public. On average, about 80,000 people at a time." When Dr. Archelle Georgiou was in clinical practice, she did the math: 15 patients a day for 30 years. The number didn't feel impactful enough. So this Johns Hopkins-trained physician made an unorthodox choice—leaving patient care to join the very managed care industry that frustrated her, determined to fix the system from within. From associate medical director at Cigna to leadership at UnitedHealth Group, Dr. Georgiou discovered that sometimes the best way to heal healthcare is to understand how it's financed and delivered. But her most powerful platform came through an unexpected channel: television. For over 16 years and 2,000 segments, she's been translating complex medical information for millions, becoming a trusted voice in America's living rooms. When COVID-19 struck and the world watched Johns Hopkins count cases and deaths, Dr. Georgiou saw what was missing: real-time hospital data. In one weekend, she and a colleague built what the entire healthcare system hadn't—a national hospital tracking dashboard that informed policymakers, appeared in major publications, and generated 12 peer-reviewed studies. In this episode of Inspiring Women with Laurie McGraw, Dr. Georgiou reveals: Why America's "paternalistic culture" makes us listen to doctors—and why we need to listen more critically How she went from treating 15 patients daily to educating 80,000 people at a time The weekend project that solved COVID's biggest data gap when no one else would Why managed care's influence on healthcare delivery shocked even an industry insider How creating annual strategic business plans for yourself can drive reinvention What really determines impact: degrees and titles, or understanding your core talents Why solving patient care problems remains her "true north" across every role From humble beginnings with parents who didn't finish elementary school to becoming a national medical correspondent, board member, and strategic advisor, Dr. Georgiou proves that maximizing your impact sometimes means leaving the traditional path behind. "Every single year I work with myself to create a strategic business plan," she shares. "A $10 million business has a business plan every single year. So why don't you?" A calculated risk-taker who's never afraid to walk through doors that inch open, Dr. Archelle Georgiou continues to reinvent what it means to be a physician leader—one who measures success not in patients seen, but in lives transformed through education, advocacy, and evidence-based truth. Chapters 2:15 - From Physician to Managed Care Leader 5:40 - Why Healthcare is So Hard to Navigate 9:30 - The Power of Media: Reaching 80,000 People at Once 13:45 - COVID Crisis Response: Building the Hospital Data Dashboard 18:20 - Leadership Across Five Tracks 20:50 - Annual Personal Strategic Planning 23:30 - Finding Your Core Talents Beyond Your Degree 26:00 - The Storyteller-Healthcare-Data Formula Guest & Host Links Connect with Laurie McGraw on LinkedIn Connect with Archelle Georgiou, MD on LinkedIn Connect with Inspiring Women Browse Episodes | LinkedIn | Instagram | Apple | Spotify

Unfortunately, more Americans are using their 401(k)'s for financial emergencies I'm sure some will disagree with me based on the headlines arguing they were so happy that they had their 401(k) to tap for whatever their financial emergency was. In my opinion, people are thinking short term and not thinking about the long-term crisis when they retire in 20 or 30 years and then might be living at the poverty level because their 401(k) was not large enough to generate a decent income and social security was far less than they thought. I also want people to understand based on how fast medical technology is moving, in 20 to 30 years you may be spending more time in retirement than the 20 years or so that you were thinking. The numbers are frightening when I look at them and I have wished many times that the 401(k) would eliminate the ability to access funds before retirement like the old pension plans from companies. According to Vanguard, 2024 saw a record of 4.8% of workers that took a hardship distribution for a financial emergency. This was more than double the 2% level in 2019. Even more frightening was nearly 33% of people decided to take and cash in their 401(k) when they changed jobs in spite of the fact of paying taxes and penalties as opposed to rolling that retirement over to an IRA rollover or their new 401K plan. Congress in their infinite wisdom has made it easier to qualify for withdrawals from 401(k)'s for emergencies. I believe the Congress that set up the 401K in 1978 under The Revenue Act of 1978 did not envision the raiding of 401(k)'s for emergencies. I'm pretty confident in 1978 Congress felt this would be a great retirement plan for all Americans, not an emergency fund of to pay off debt. I highly recommend before people take any money out of the 401(k), they talk to a real financial professional to understand the taxes and penalties they are paying. It's not just the taxes and penalties, and one should also figure out the future value of what that account could have grown to and how that withdrawal could devastate their retirement!   Inflation report shows some positives and some negatives The July Consumer Price Index, also known as CPI, showed an annual increase of 2.7%, which was in line with June's reading and below the expectation of 2.8%. The headline number was helped by energy, which showed an annual decline of 1.6%, largely thanks to a decline of 9.5% for gasoline. Energy services on the other hand were not as favorable considering an increase of 5.5% for electricity and 13.8% for utility (piped) gas service. I do wonder if the power demand for these large data centers is starting to put a strain on the grid and I worry this could become even more problematic. As for core CPI, which excludes food and energy, it was up 3.1% from a year ago and was slightly above the forecast of 3%. This was a slight increase from the 2.9% level in June and the highest annual increase since February. Surprisingly, shelter continues to be a large reason for the elevated inflation rate as it was still up 3.7% compared to last year. In terms of tariffs showing up in the report, it still appeared to be subdued. Furniture was up 7.6% compared to last year, but other areas that I would anticipate seeing pressure like apparel and new vehicles saw little change. New vehicle prices were up just 0.4% compared to last year and apparel prices were actually lower by 0.2%. I did see an economist point out the fact that core goods inflation on an annual basis registered the largest growth in over two years, but at 1.2% I wouldn't say that is putting strain on the economy. These tariffs will likely put continued pressure on inflation, but if other areas like shelter continue to see less inflation that could counteract that pressure and keep overall inflation in a manageable situation. Based on the slowing labor market and these manageable levels of inflation I do believe the Fed should cut in September.   What does the national debt surpassing $37 trillion mean for you?  On Tuesday, August 12th, the United States national debt passed $37 trillion for the first time ever. The debt is growing at about $6 billion per day, but that appears to be better than last year. In July 2024, the national debt passed $35 trillion and then in November 2024 it surpassed $36 trillion. Looking for some positives here, it did take nine months for the debt to grow another $1 trillion to the $37 trillion mark. At the end of the second quarter, debt to GDP stood at 119.4%, which is manageable but should not go much higher. Hopefully we can have a slowdown in debt expansion or maybe even a reversal and still have the GDP increase. The reason having a high national debt is a negative is it takes investment out of the private sector to fund our national debt, which can slow down the growth in our economy. A large national debt can also cause interest rates to increase as the need for more debt often means offering higher interest rates to attract buyers. It is also important to know that even when the Federal Reserve cuts interest rates, that generally has a larger impact on the short end of the curve, which includes instruments like treasury bills. Your long-term debt, such as 5–10-year notes are not controlled by what the Federal Reserve does and instead is based on supply and demand. It would not be a wise move for the government to only issue short-term debt for a lower rate because if rates were to increase in the future for whatever reason, that could cause our national debt to grow out of control and potentially cause a financial collapse. Also, keep in mind that generally mortgage rates align with the rates for longer term debt and now with some car loans being six or seven years, the interest rates for those loans will probably not drop because they are now longer-term loans not the old 3-to-4-year loans they used to be. We are not in trouble yet, but we are getting close to the edge and we need to grow the economy and still reduce the national debt so our country can continue to prosper and grow.   Financial Planning: Changes Coming to Charitable Giving The One Big Beautiful Bill Act, signed on July 4, 2025, delivers some new changes coming to how charitable giving may be deducted. For the first time since the pandemic-era CARES Act, those who claim the standard deduction will be able to deduct cash donations up to $1,000 for single filers and $2,000 for joint filers.  This will act as an above-the-line deduction in addition to the standard deduction.  For itemizers, however, the law imposes a new 0.5% of AGI floor, meaning only contributions above that threshold will count toward deductions, potentially reducing benefits for those making smaller annual gifts. For example, a tax filer with an AGI of $200,000 receives no tax benefit on the first $1,000 (.5%) of donations. Also, itemizers are not able to take advantage of the $1,000 to $2,000 above-the-line charitable deduction that standard deduction filers can.  In addition, high earners who are in the 37% tax bracket will only receive a 35% deduction on charitable donations. All of these changes go into effect in 2026, so those claiming the standard deduction may want to wait until then while itemizers and high earners may want to make donations before the end of the year.   Companies Discussed: Intel Corporation (INTC), UnitedHealth Group Incorporated (UNH), Nexstar Media Group, Inc. (NXST) & Bloomin' Brands, Inc. (BLMN)

Carl Quintanilla, Scott Wapner and Mike Santoli discussed UnitedHealth Group leading the Dow to a new all-time high -- after Warren Buffett's Berkshire Hathaway disclosed a $1.6 billion stake in the health insurer, whose stock remains the Dow's worst performer this year. The anchors also reacted to reports the Trump Administration is in talks with Intel to have the U.S. government acquire a stake in the chipmaker. Also in focus: Applied Materials tumbles on weak guidance, July retail sales rise, what Chicago Fed President Austan Goolsbee told CNBC about tariffs and rate cuts, software stocks slump, Target downgraded, Trump-Putin summit. Squawk on the Street Disclaimer

Big names are making bold moves, and markets are reacting. Hosted by Michelle Martin with Ryan Huang, today’s episode breaks down Berkshire Hathaway’s latest portfolio addition — UnitedHealth Group — and why Michael Burry’s joining the party. We dive into the fierce e-commerce battle between JD.com, Alibaba, and Meituan, plus CK Hutchison’s profit drop and Jollibee’s surprising growth. Intel’s shares jump on talk of a potential U.S. government stake, while a new listing hits Singapore’s Catalist Board. We wrap with how inflation pressures in the U.S. could shape the Fed’s next move. Companies mentioned: Berkshire Hathaway, UnitedHealth Group, JD.com, Alibaba, Meituan, CK Hutchison, Jollibee, Intel, Dezign See omnystudio.com/listener for privacy information.

The federal government slows progress on mRNA vaccine research. UnitedHealth Group and Amedisys resolve a key legal challenge, clearing the way for their multibillion-dollar merger. And Vertex Pharmaceuticals experiences a delay in its development of a new class of non-opioid pain therapies. Those stories on today's episode of the Gist Healthcare Podcast. Hosted on Acast. See acast.com/privacy for more information.

It's nearly impossible to discuss the private health insurance landscape in America without referencing the killing of UnitedHealthcare CEO Brian Thompson last December.The shooting unleashed a wave of antipathy directed at insurers and brought deep-seeded, longstanding grievances against these for-profit health entities to the fore.In the intervening months, UnitedHealth Group and the broader insurer class have suffered significant damage not only to their respective bottom lines, but also their corporate reputations.Given the current state of play, we wanted to hear how medical marketers are navigating this uniquely challenging situation.Reporter Heerea Rikhraj speaks with Shannon Langrand, CEO of her namesake agency, about how health insurers are being marketed in 2025 as well as what challenges are lingering in the payer space.For our Trends segment, we parse through the Sarepta Therapeutics saga and pull out some key takeaways. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music.

Health and Human Services Secretary Robert F. Kennedy Jr. reportedly plans to fire the panel tasked with making preventive services recommendations. UnitedHealth Group slashes its 2025 outlook amid rising medical costs. And, pediatric flu deaths reach highest level outside of a pandemic season. Those stories and more coming up on today's episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

En el episodio de hoy de VG Daily, Andre Dos Santos y Eugenio Garibay se sumergen en el análisis más completo y actualizado sobre los reportes trimestrales de algunas de las empresas más influyentes del mercado: Procter & Gamble, Spotify, PayPal, UPS, UnitedHealth Group, Novo Nordisk y Boeing. Conversan sobre cómo estos resultados sorprendieron –o decepcionaron– tanto a analistas como al público inversionista, examinando a fondo las razones detrás de las reacciones del mercado y los momentos de mayor emoción o preocupación que dejó cada reporte.Además, exploran el estado general del mercado, donde las guías conservadoras, la volatilidad y la presión competitiva están definiendo el tono de la temporada de earnings. 

UnitedHealth Group faces a criminal and civil investigaiton from the Department of Justice, the company disclosed Thursday. ABC News investigatiev reporter joined Arizona's Morning News to talk about this investigation and if it will cause your insurance prices to rise.

P.M. Edition for July 24. President Donald Trump took a rare step visiting the Federal Reserve. The $2.5-billion renovation to its headquarters has gotten renewed attention this month as Trump has ramped up pressure on Federal Reserve Chair Jerome Powell. WSJ White House reporter Meridith McGraw discusses what this might mean for the Fed's meeting next week. Plus, Walmart has built dozens of artificial intelligence agents to interface with everyone from customers to suppliers. Now the retailer is overhauling its approach; WSJ enterprise technology reporter Isabelle Bousquette explains why. And, for the first time, UnitedHealth Group has confirmed it's responding to Justice Department probes. Alex Ossola hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

But some large component stocks dragged on the Dow Jones Industrial Average, including UnitedHealth Group. The health conglomerate disclosed that it is cooperating with criminal and civil investigations by the U.S. Justice Department. Plus: Tesla shares slid after Elon Musk's electric vehicle-maker said car sales continued to fall for another quarter. Danny Lewis hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

UnitedHealth Group said Thursday it is cooperating with civil and criminal requests from the United States Department of Justice over its Medicare practices. The Wall Street Journal reported in May that the U.S. Department of Justice is investigating the Minnesota-based company for criminal Medicare fraud. This comes after a civil probe into UnitedHealth the newspaper reported earlier this year and a series of articles about the company's billing practices. The Wall Street Journal found UnitedHealth had received billions of dollars from Medicare for diagnoses that some doctors said were incorrect or irrelevant. Wall Street Journal reporter Anna Mathews joined Minnesota Now to talk about the reporting.

Congress holds another hearing on antisemitism, and university leaders once again allow politicians to dictate university policies and faculty decisions. Plus: New York Times reporter and author David Enrich exposes the sinister ways UnitedHealth Group censors its critics online.  ------------ Watch full episodes on Rumble, streamed LIVE 7pm ET. Become part of our Locals community Follow System Update:  Twitter Instagram TikTok Facebook  

In this episode, Jakob Emerson, Associate News Director at Becker's Healthcare, joins Scott Becker to break down key developments in the payer world including a deepening DOJ investigation into UnitedHealth Group's Medicare Advantage billing and the far-reaching implications of the newly passed One Big Beautiful Bill.

992: “Healthcare, first of all, unlike other industries, has to be held to a higher standard in terms of responsibility.” In this episode of Technovation, host Peter High speaks with Sandeep Dadlani, Executive Vice President and Chief Digital & Technology Officer of UnitedHealth Group, the Fortune 3 healthcare leader. Sandeep explains how his team's technology and digital strategies are tightly aligned to UnitedHealth Group's mission: helping people live healthier lives and making the health system work better for everyone. He shares how AI, cloud, and data-driven innovations improve care delivery, enhance provider and patient experiences, and reduce administrative burden while driving transformation at scale.

Accused of several despicable acts of malpractice, May has been a rough month for UnitedHealth Group. It is suffering a drop in stock value, reduced earnings projections and a loss of confidence.  One of the many accusations includes pressuring or bribing 2200 nursing homes to refuse the transfer of patients to hospitals, thereby saving the company many large claims. In the "Your Medicare Benefits 2025" segment, we learn how Medicare would cover kidney transplants. On a very serious subject, 11% of Medicare participants rely solely on original Medicare. This has the possibility of turning out to be a big mistake. Even if one has the deepest of deep pockets, neglecting to carry insurance to supplement Medicare Parts A & B can leave one in a position of being refused treatment for elective or non-emergency medical procedures. Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2025; Simplest & Easiest Guide Ever!" on Amazon.com. Return to leave a short customer review & help future readers. Official website: https://www.MedicareForTheLazyMan.com.

Officials are working on plans for a funeral for Representative Melissa Hortman and her husband Mark. We share remembrances from a vigil at the state capitol. Plus, the Minnesota Legislature is set more regulations for data centers that are popping up around the state.We normally assume city centers are generally safe from tornadoes, but that may be a myth. We learn more from an expert.Minnesota-based UnitedHealth Group has sued a media company for defamation. We break down what implications the case could have on press freedom. Plus, you hear from residents of a small town whose lives were touched by a man they are calling the “Northfield Angel.”It's Juneteenth! We hear from the latest winners of the Miss Juneteenth Minnesota Pageant.

Eden Prairie-based UnitedHealth Group is suing the international news organization, The Guardian, for defamation. The Guardian article in question explores how UnitedHealth engaged in cost-cutting tactics by paying off nurses to cut down on hospital transfers. The Guardian cited internal emails, documents and interviews with more than 20 current and former staffers.But the health insurance company claims the paper ran information it knew to be incorrect to capitalize on the killing of CEO Brian Thompson. Jane Kirtley, a professor of media law and ethics at the University of Minnesota, broke down the lawsuit on Minnesota Now.

My client had the best Medicare insurance available at a very small cost, but decided to drop Part B and her Medicare supplement for over a year while waiting for Social Security enrollment. Bad move! She has been diagnosed with atrial fibrillation. She now must wait until next year to re-enroll in Part B and she may never qualify to get her great supplement again. We started this episode by detailing some of the employee layoffs that at least 18 insurance companies must endure due to uncontrolled expenses. This apparently includes 30,000 to be terminated from United Health Group, the largest health insurance company of them all. In the "Your Medicare Benefits 2025" segment, we learn how Medicare covers Kidney Disease Education for those suffering from those afflictions. Finally I give a short history of the origins and a couple of the quirks of Part D prescription drug plans.      Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2025; Simplest & Easiest Guide Ever!" on Amazon.com. Return to leave a short customer review & help future readers. Official website: https://www.MedicareForTheLazyMan.com.

Health and Human Services Secretary Robert F. Kennedy Jr. names new members to a CDC vaccine advisory panel days after he removed existing members. UnitedHealth Group's credit rating is downgraded. And, states sue bankrupt DNA testing company 23andme to protect consumers' genetic data. Those stories coming up on today's episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

This is Zack Fuss. Today, we're tackling a giant in a controversial and incredibly complex industry, UnitedHealth Group. At its recent apex, UNH was a half-trillion-dollar market cap business, the 15th largest listed business in the United States. Today, that market cap sits at just $275 billion. The company generates an excess of $400 billion in sales annually and produces $40 billion in EBITDA as it touches every facet of the American healthcare system. To break down UnitedHealthcare, I'm joined by Stephanie Niven, a co-PM of the Global Sustainable Equity Strategy within the Sustainable Equity Team at Ninety One. Stephanie has been following the company since 2012 and she helps us to unravel this intricate business. We explore how UnitedHealthcare operates as a fully integrated healthcare system from its insurance arm to its high-margin health services business. We also dive into the concept of value-based care, the recent headwinds from Medicare Advantage scrutiny, and whether the market is mispricing this complex giant amidst regulatory noise and leadership changes. Please enjoy this breakdown of UnitedHealth Group. ⁠⁠Subscribe⁠⁠ to Colossus Review For the full show notes, transcript, and links to the best content to learn more, check out the episode page⁠ ⁠here⁠⁠. —- This episode is brought to you by Octus, formerly Reorg, is the essential credit intelligence and data provider for nearly 40,000 professionals across the world's leading buy side firms, investment banks, law firms and advisory firms. By surrounding unparalleled human expertise with embedded AI technology, data and workflow tools, Octus unlocks powerful truths that fuel decisive action in financial markets. Visit⁠⁠ octus.com⁠⁠ to learn how rigorously verified intelligence is delivered at speed to create a complete picture across the entire credit lifecycle. —- Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit⁠⁠ joincolossus.com/episodes⁠⁠. Editing and post-production work for this episode was provided by The Podcast Consultant (⁠⁠https://thepodcastconsultant.com⁠⁠). Show Notes (00:00:00) Welcome to Business Breakdowns (00:04:51) Understanding the US Healthcare System (00:10:24) UnitedHealth Group's Origins and Evolution (00:13:41) UnitedHealth Group's Business Model (00:22:36) Optum: The Overlooked Powerhouse (00:29:24) Value-Based Care: A New Approach (00:34:51) Current State of US Healthcare System (00:36:49) Regulatory Scrutiny and Media Attention (00:37:27) Investor Concerns and Company Response (00:42:49) Structural vs. Cyclical Issues (00:48:42) UnitedHealth's Technological Edge (00:52:07) Political Risks and Regulatory Environment (00:57:16) Medicare Advantage: A Closer Look (01:02:02) Lessons from UnitedHealth's Strategy

In this timely roundtable, Lisa and Hemma sit down with Mary Inman and Liz Soltan, two powerhouse advocates in the whistleblower legal space, to unpack the DOJ's newly revised Corporate Whistleblower Awards (CWA) Pilot Program and its implications for the compliance community.  We also explore what makes whistleblowing work, how to support internal and external reporters, and why this moment may mark a turning point for global whistleblower engagement. Highlights: Mary and Liz break down the newly added DOJ priority areas How the CWA Pilot Program could evolve into a DOJ equivalent of the SEC whistleblower program Why organizational justice and psychological safety must be embedded into internal reporting systems. How tips must result in asset forfeiture to trigger awards Why we need a speak-up culture, not just a hotline Resources  DOJ's May 2025 Criminal Division White-Collar Enforcement Plan Revised DOJ Corporate Whistleblower Awards Pilot Program: DOJ Announcement Speech by Matthew R. Galeotti at the SIFMA AML and Financial Crimes Conference Link to speech Whistleblowing Study by Stephen Stubbens and Kyle Welch Whistleblower Partners LLP: Mary Inman, Liz Soltan Biographies   Mary Inman Partner, Whistleblower Partners LLP Mary Inman is a seasoned attorney with over 30 years of experience representing whistleblowers under various U.S. programs, including the False Claims Act, SEC, CFTC, IRS, FinCEN, and NHTSA/DOT. After spending three years in London, she now focuses on international whistleblowers exposing misconduct with ties to the U.S.. She assists clients in bringing claims to foreign regulators such as the Ontario Securities Commission and the Canada Revenue Agency. Mary is renowned for her expertise in healthcare, tech, and financial services fraud. She has represented high-profile whistleblowers like Frances Haugen (Facebook) and Tyler Shultz (Theranos), and co-authored The Tech Workers' Handbook, a guide for tech industry whistleblowers. Her advocacy extends to testifying before global governmental bodies, including the European Commission and UK Parliament, championing the effectiveness of U.S. whistleblower programs. Mary holds a J.D. from the University of Pennsylvania Law School and has clerked for judges in both the U.S. District Court and the U.S. Court of Appeals. Outside of her legal work, she enjoys participating in her husband's YouTube channel and spending time in northern Maine. Liz Soltan Associate, Whistleblower Partners LLP Liz Soltan is an associate at Whistleblower Partners LLP, focusing on cases involving financial fraud, anti-money laundering, and sanctions evasion. Her notable work includes representing a foreign whistleblower in a FinCEN sanctions violation case concerning illegal sales to Russia. Liz also contributed to the landmark Medicare Advantage risk adjustment fraud case, United States ex rel. Poehling v. UnitedHealth Group, Inc. Before joining Whistleblower Partners, Liz served as a Skadden Fellow at Community Legal Services of Philadelphia, where she was part of a team that secured $712 million in emergency food stamp benefits for 650,000 households during the COVID-19 pandemic. She earned her J.D. cum laude from Harvard Law School, where she led the Wage and Hour Practice Group at the Harvard Legal Aid Bureau and successfully argued a workers' rights case before Massachusetts' highest court. Liz completed her undergraduate studies at Cornell University, graduating summa cum laude with a major in History and a minor in Spanish. Residing in Brooklyn, Liz maintains strong ties to her Philadelphia roots. She enjoys participating in a fiction-only book club, exploring historical sites, and spending time with her husband, son, and their two cats, Alex Trebek and Vanna White.

Story of the Week (DR):Boeing strikes $1.1 billion deal with Justice Department over deadly 737 Max crashes—and must pay $445 million to victims' familiesBoeing will avoid a felony conviction by agreeing to pay over $1.1 billion, which includes a $243.6 million fine, $444.5 million to victims' families, and more than $455 million to enhance compliance, safety, and quality systems.The families were informed nearly a week after the DOJ said it had struck a tentative deal with Boeing that allows the company to avoid criminal prosecution for allegedly misleading regulators about the company's 737 Max plane before two crashes that killed 346 people.Market Basket CEO Arthur T Demoulas placed on administrative leave by board of directorsDemoulas has been placed on paid administrative leave by the company's board of directors, along with two of his children and several other executives.The board initiated an internal investigation into Demoulas' conduct, citing concerns over transparency and succession planning. Specifically, the board expressed frustration over limited access to critical company information, including budgets and plans for leadership succession, and alleged that Demoulas was planning a work stoppage. Demoulas has responded through a spokesperson, claiming he was "ousted" in what he describes as a "farcical cover for a hostile takeover." This situation echoes a similar family dispute in 2014, which led to widespread employee protests and customer boycotts in support of Demoulas. The current conflict raises questions about the company's leadership and future direction amid ongoing supermarket industry consolidationIn June 2014, CEO Arthur T. Demoulas was ousted by a board controlled by his cousin, Arthur S. Demoulas, amidst longstanding family disputes over company control.Customer: “If the employees think another walkout makes sense, then I'd support them. Basket ‘til the casket.Market Basket, a regional supermarket chain in New England, generates an estimated $7.3 billion in revenue. The company employs approximately 25,000 people. The revenue projection is roughly double what it was in 2014.Market Basket director: CEO Demoulas took company 'hostage'The Fake Elon government exit: A Disillusioned Musk, Distanced From Trump, Says He's Exiting Washington MMPer 18 U.S.C. § 202 (a), a Special Government Employees (SGE) is “an officer or employee . . . who is appointed to perform temporary duties, with or without compensation, for a period not to exceed 130 days during any period of 365 consecutive days.”Elon Musk says he doesn't "entirely agree" with Trump administration, explains why he feels "stuck in a bind""But it's difficult for me to bring that up in an interview because then it creates a bone of contention," he said. "I'm a little stuck in a bind, where I'm like, well, I don't wanna, you know, speak up against the administration, but I … also don't wanna take responsibility for everything the administration's doing. So I'm, like, kinda stuck, you know?"Deepfake ElonFalse StartAugust 2006: “[Our] long term plan is to build a wide range of models, including affordably priced family cars … When someone buys the Tesla Roadster,” he added, “they are actually helping pay for development of the low-cost family car.”2016: Musk reiterated that, even though Tesla had not yet delivered on the 2006 promise, it still planned to build an “affordable, high-volume car.”January 2025: Musk said that—finally—Tesla would start producing the affordable model in the second half of 2025.April 2025: Reuters reported that Tesla had scrapped plans for the cheap family car. Musk posted on X that “Reuters is lying (again),” eliciting the Reuters response that “[Musk] did not identify any specific inaccuracies.” A Tesla source told Reuters that instead of the long-promised cheap family car, “Elon's directive is to go all in on robotaxi.”Hyperloop HypeAugust 2013: “A new open source form of transportation that could revolutionize travel.”The Hyperloop was shuttered in 2023—but even as late as 2022, Musk was still promising that Hyperloop could go from Boston to New York City “in less than half an hour.”Driverless PioneeringSeptember 2013: “We should be able to do 90 percent of miles driven [autonomously] within three years.”Full Autonomous DrivingOctober 2015: “Tesla will have a car that can do full autonomy in about three years.”December 2015: “We're going to end up with complete autonomy … and I think we will have complete autonomy in approximately two years.”January 2016: “I think that within two years you'll be able to summon your car from across the country.”.June 2016: “I consider autonomous driving to be a basically solved problem … We're less than two years away from complete autonomy.”November 2018: “I think we'll get to full self-driving next year.”Autonomous ChargingOctober 2016: “we'll be able to do a demonstration drive of full autonomy all the way from LA to New York—from home in LA to let's say dropping you off in Time Square in New York, and then having the car go park itself—by the end of next year … without the need for a single touch, including the charger.”In April 2017: “I think we're still on track for being able to go cross-country from LA to New York by the end of the year, fully autonomous … Just software limited.”BoringApril 2017: The Boring Company was supposed to deliver an underground maze of tunnels where passengers could travel in autonomous vehicles at 150 miles per hour.The goal was to build one mile of tunnel per week: “Finally, finally, finally, there is something that I think can solve the goddamn traffic problem.”So far: the 1.7-mile LVCC Loop in Las Vegas: currently takes paying passengers between three stations in chauffeur-driven Model Y Tesla cars which slow to just 15 miles per hour when the tunnels get congested.Brain ChipsAugust 2017: First product would be on the market “in about four years.”In 2024: the first human trial subject receives a Neuralink implant (though some researchers show frustration over a lack of information about the study.)Special DeliveryNovember 2018: “Probably technically be able to [self-deliver Teslas to customers' doors] in about a year.”FSD Finally?January 2019: “When do we think it is safe for full self driving?” asks Musk on a Q4 earnings call. “Probably towards the end of this year.”Feb 2019: “We will feature complete [with] full self-driving this year … The car will be able to … take you all the way to your destination without an intervention this year. I'm certain of that. That is not a question mark.”January 2021, on an earnings call: “I'm highly confident the car will drive itself for the reliability in excess of a human this year. This is a very big deal.”December 2021: “It's looking quite likely that it will be next year,” he says.May 2023: “I mean, it does look like [full autonomy is] gonna happen this year.”One Million RobotaxisApril 2019: “We expect to have the first operating robot taxi next year with no one in them … Next year for sure, we'll have over a million robotaxis on the road.”April 2025 earnings call: Musk says that Tesla will unveil its robotaxi service in Austin, Texas, next month, with up to 20 Model Y vehicles supervised remotelyLevel Five Is AliveJuly 2020: “I'm extremely confident that level 5–or essentially complete autonomy–will happen … this year … There are no fundamental challenges remaining,” he stated.December 2020: “I'm extremely confident that Tesla will have level 5 next year,” Musk tells Mathias Döpfner, the CEO of Business Insider's parent company, Axel Springer SE. How confident? “100 percent,” replies MuskMusk also tells Döpfner that a human will possibly step onto Mars by 2024.April 2025 earnings call: “We'll start to see the prosperity of autonomy take effect in a material way around the middle of next year … There will be millions of Teslas operating autonomously, fully autonomously in the second half of next year.”March 2025: Babysitting Robot Army2021: “hopefully” Tesla will be able to make about 5,000 Optimus robots this year. Musk then claimed Tesla would make “probably 50,000-ish [Optimus robots] next year.”Optimus “will be the biggest product of all time by far—nothing will even be close. It'll be 10 times bigger than the next biggest product ever made. Ultimately, I think we'll be making tens of millions of robots a year.” Mere seconds later: “Tesla would actually make “maybe 100 million robots a year.”April 2025: he told investors that production could be impacted by the restrictions on rare-earth metal exports China implemented in response to President Trump's tariffs. There's no date yet for the launch of Optimus.ESG inventor says Trump its 'best possible advert'Paul Clements-Hunt, credited with coining the term "ESG", views Trump's opposition to ESG investing as inadvertently beneficial for the movement.Clements-Hunt argues that Trump's criticisms have heightened public awareness and discourse around ESG principles, effectively serving as a "best possible advert" for ESG by bringing it into mainstream conversations.He suggests that the backlash has prompted companies and investors to more rigorously define and implement ESG strategies, moving beyond superficial commitments2025 U.S. Proxy Season: Midseason Review Finds Sharp Drop in Shareholder Resolutions on Ballot Goodliest of the Week (MM/DR):DR: Penguin Poop: The Latest Tool to Fight Climate Change DRPenguin guano releases high concentrations of ammonia, which reacts with sulfur compounds in the atmosphere to form aerosols. These aerosols facilitate cloud formation, potentially cooling the Earth's surface and preserving Antarctic ice. MM: State Comptroller votes to prioritize fiduciary duty for proxy votingState Comptroller Elise Nieshalla, Indiana Deferred Compensation CommitteeThe new policy, Bowyer Research Proxy Voting Guidelines , provides a voting framework solely focused on shareholder value.Live case study in whether Bowyer votes against directors! Remember when Strive said they voted anti-woke, and really they just voted against women? Now we'll find out if Bowyer uses Free Float data secretly or if they just vote against brown peopleMM: Volkswagen executives get prison time in 'Dieselgate' scandalAssholiest of the Week (MM): Tesla investors demand Musk work 40-hour week at EV maker as 'crisis' buildsJack Dorsey, Twitter's Eccentric CEO, Could Be Looking For A Job SoonElliott is concerned that Dorsey hasn't focused enough on Twitter, because he is also chief executive of payments company Square. The hedge fund is pushing for a CEO whose sole job is running Twitter.CEOsWells Fargo's Scharf Says CEOs Are WorriedCEO pay rose nearly 10% in 2024 as stock prices and profits soaredMore money!Activist Investor Accuses Penn CEO Of Using Company Jet As 'Personal Uber,' Citing Losses And Barstool DebaclePerks!Anthropic CEO warns AI could eliminate half of all entry-level white-collar jobsEven more money!CEO Jensen Huang to Sell $800 Million of Nvidia StockEven more more money!UnitedHealth Group faces lawsuit claiming it used ex-employees' 401(k) funds to defray its own costs DRThe vote on the board is MondayThe company offered the Executive Chair and former CEO Stephen Hemsley $60m in non-performance based options at the near nadir of the stock price, vesting in 3 years, that we estimate will equal roughly $170m in value if the stock price returns to where it was just 6 months agoHe is the highest influence director even BEFORE Witty quit in disgrace - he's likely to have as much as 40% influence when we remove WittyThe company is under investigation for defrauding Medicare, they had an executive assassinated, they have effectively denied coverage for thousands of customers, and now they were stealing from their own employees… and you can vote them outHalf brained idea:James G. Davis, Jr. Announces Retirement from American Woodmark Board of DirectorsHe's 65 years old, been there for 23 years, decides to step downHow about this - make boards a LIFETIME position, no votesWouldn't investors actually pay attention if every director was “elected” just ONCE? They could be like the supreme court and serve until they die or retireHeadliniest of the WeekDR: Musk's SpaceX town in Texas warns residents they may lose right to ‘continue using' their propertyDR: 9 of the most out there things Anthropic CEO Dario Amodei just said about AIOn when he thinks the world will see the first billion-dollar company with one employee.“2026”MM: Nearly Half of Young People Wish the Internet Had Never Been InventedWho Won the Week?DR: Boeing CEO Kelly Ortberg: DOJ looks the other way a week after Boeing secured a record-breaking $96 billion order from Qatar Airways during Donald Trump's trip.MM: Grok: Marjorie Taylor Greene beefs with Elon Musk's AI chatbot: 'The judgement seat belongs to GOD'PredictionsDR: RFK Jr. discovers Trump Poop is more effective than 93% of the American Federation of Teachers unionMM: Vince McMahon sex trafficking case co-defendant John Laurinaitis agrees to help accuser - 100% chance he's pardoned. ONE. HUNDRED.

In this episode, Jakob Emerson, Associate News Director at Becker's Healthcare, joins Scott Becker to unpack the stunning recent upheaval at UnitedHealth Group, from stock plummets and leadership shakeups to DOJ investigations.

Investment banks downgrade UnitedHealth Group amid ongoing challenges. The Food and Drug Administration changes its COVID-19 guidelines, restricting the shots to certain at-risk groups. And, Cigna's Evernorth subsidiary will cap the cost of pricy weight loss drugs for members. Those stories and more coming up on today's episode of Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

United Health Group is having a bad, bad time. Let us tell you the fascinating and frustrating reasons why the stock recently lost a whopping $200 BILLION in value. Give this video a thumbs up if you enjoyed it! And please leave us a comment! It helps us! DENVER we are coming for you. Get tix here: https://comedyworks.com/comedians/ben-emil-live Our PORTLAND VIDEO IS OUT! https://youtu.be/qX4pks0ASq8 Sign up to watch and support the show at https://benandemilshow.com ***LINK TO OUR DISCORD: https://discord.gg/CjujBt8g ***Subscribe to Emil's Substack: https://substack.com/@emilderosa ***Trade with Ben at https://tradertreehouse.com Our episode with *Kyla Scanlon*: https://youtu.be/cIHWkY35cuc Big Tech is out of ideas (ft. ED ZITRON): https://youtu.be/zBvVGHZBpMw Arguing with a millionaire (ft. Chris Camillo): https://youtu.be/1ZUWTkWV_MM We bought suits HERE: https://youtu.be/_cM1XqA9n2U __ ROCKET MONEY: Cancel your unwanted subscriptions and reach your financial goals faster with Rocket Money! Go to https://rocketmoney.com/baes today! MUD/WTR: Start your new morning ritual and get up to 43% off your @MUDWTR with code BAES at https://mudwtr.com/baes #mudwtrpod SHOPIFY: Turn your big business idea into reality with Shopify on your side! Sign up for your one dollar per month trial and start selling today at https://shopify.com/baes HIMS: Fellas! Keep your hair thick and full! Start your FREE online visit today at https://hims.com/baes __ This episode was edited by Connor Rousseau / @ conrad_roussrad Follow us on instagram! @ benandemilshow @ bencahn @ emilderosa Learn more about your ad choices. Visit podcastchoices.com/adchoices

I was going to talk about corneas. Just a nice, focused anatomy deep dive. But then I found out UnitedHealthcare's stock is down 20% and—what can I say? I got distracted by joy. So before we dig into layers of corneal meat (yes, I said that), we take a little detour into vertical integration, kickbacks, AI claim denials, and how a multi-billion-dollar behemoth is finally catching a whiff of accountability. Then it's back to business: corneal nerves, LASIK, ulcers, transplant techniques, the great “your corneas are too thin” letdown, and why you should stop sleeping in your contact lenses. Also, I may have created a dating strategy that involves casually name-dropping Descemet's membrane. You're welcome. Takeaways: UnitedHealth Took a Hit—And I Took a Victory Lap. Their CEO is stepping down. Their stock is down. Their karma might finally be catching up. I am… not sad. Your Cornea Is Clear for a Reason—Until It's Not. It doesn't have blood vessels. It doesn't heal like skin. And when it gets cloudy, things get gross, fast. LASIK Isn't for Everyone. Here's Why Your Eye Got Rejected. If you've ever been told your cornea is “too thin,” I'm here to explain why—and yes, it's as mathy as it sounds. Yes, I Called It ‘Corneal Meat.' No, I'm Not Sorry. It's the stroma. It's thick. It's important. And now you're never going to un-hear that phrase. Please Stop Sleeping in Your Contacts. I'm Begging. Because you like seeing. And because I don't want to have to dig bacteria out of your eyeball. — To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠  Also, be sure to check out the newsletter: https://glaucomflecken.com/glauc-to-me/ If you are interested in buying a book from one of our guests, check them all out here: https://www.amazon.com/shop/dr.glaucomflecken If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: https://anatomywarehouse.com/?aff=14 Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠ for more information.  Today's episode is brought to you by DAX Copilot from Microsoft. DAX Copilot is your AI assistant for automating clinical documentation and workflows helping you be more efficient and reduce the administrative burdens that cause us to feel overwhelmed and burnt out. To learn more about how DAX Copilot can help improve healthcare experiences for both you and your patients visit ⁠⁠⁠⁠aka.ms/knockknockhi⁠⁠⁠⁠. To learn more about Pearson Ravitz go to ⁠⁠⁠http://www.pearsonravitz.com/knockknock⁠⁠⁠. Produced by⁠⁠⁠⁠ Human Content Learn more about your ad choices. Visit megaphone.fm/adchoices

Today's Headlines: In Palm Springs, California, a car explosion outside a fertility clinic killed the 25-year-old suspect and injured four others in what the FBI has labeled an act of intentional terrorism. The suspect's online manifesto suggested he was motivated by a fringe “pro-mortalist” philosophy, opposing the creation of life. In New York, a Mexican Navy training ship on a global goodwill tour collided with the Brooklyn Bridge after losing power, killing two people and injuring twenty. Former President Joe Biden announced that he has been diagnosed with an aggressive, hormone-sensitive form of prostate cancer that has spread to his bones, but his medical team remains optimistic about management. In a 7-2 ruling, the Supreme Court blocked the Trump administration's plan to deport Venezuelans to a prison in El Salvador without sufficient legal process, emphasizing the need for due process protections. In economic news, former President Trump criticized Walmart's plan to raise prices in response to tariffs, insisting the company should absorb the costs, while Moody's downgraded the U.S. credit rating due to rising debt and interest payments. Boeing may escape a guilty plea related to the 737 Max crashes through a tentative DOJ agreement, raising concerns among victims' families. UnitedHealth Group is now under investigation for potential Medicare fraud, and Florida has become the second state, after Utah, to ban fluoride in its public water supply. Resources/Articles mentioned in this episode: LA Times: Online manifesto threatened clinic attack; FBI probes Palm Springs bomb suspect's motive AP News: Mexican tall ship strikes Brooklyn Bridge, snapping masts and killing 2 crew members CNN: Biden diagnosed with ‘aggressive form' of prostate cancer  NBC News: Supreme Court rules administration must give Venezuelans more time to challenge deportation under Alien Enemies Act CNBC: Trump tells Walmart to ‘eat the tariffs' after retailer warned it will raise prices CNBC: Moody's downgrades United States credit rating, citing growth in government debt WA Post: DOJ plans to drop Boeing prosecution in 737 crashes, family lawyers say  WSJ: Exclusive | UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud  NBC News: Florida becomes second state to ban fluoride in public water  Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

This week: The stock market is coming back after its post Liberation Day fall. Felix Salmon, Emily Peck, and Elizabeth Spiers discuss what this does, and mostly doesn't, signal about the economy under Trump. Then, one stock that is not doing well at all is the UnitedHealth Group. The hosts explain the perfect storm the company has found itself in, and examine if that's actually the reason for its decline in the market. And finally, did you know there was insurance for self-defense shootings and AI chatbot errors? In the Slate Plus episode: Can a (very expensive) calendar fix your marriage?  Want to hear that discussion and hear more Slate Money? Join Slate Plus to unlock weekly bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Slate Money show page on Apple Podcasts and Spotify. Or, visit slate.com/moneyplus to get access wherever you listen. Podcast production by Jessamine Molli and Cheyna Roth. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week: The stock market is coming back after its post Liberation Day fall. Felix Salmon, Emily Peck, and Elizabeth Spiers discuss what this does, and mostly doesn't, signal about the economy under Trump. Then, one stock that is not doing well at all is the UnitedHealth Group. The hosts explain the perfect storm the company has found itself in, and examine if that's actually the reason for its decline in the market. And finally, did you know there was insurance for self-defense shootings and AI chatbot errors? In the Slate Plus episode: Can a (very expensive) calendar fix your marriage?  Want to hear that discussion and hear more Slate Money? Join Slate Plus to unlock weekly bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Slate Money show page on Apple Podcasts and Spotify. Or, visit slate.com/moneyplus to get access wherever you listen. Podcast production by Jessamine Molli and Cheyna Roth. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week: The stock market is coming back after its post Liberation Day fall. Felix Salmon, Emily Peck, and Elizabeth Spiers discuss what this does, and mostly doesn't, signal about the economy under Trump. Then, one stock that is not doing well at all is the UnitedHealth Group. The hosts explain the perfect storm the company has found itself in, and examine if that's actually the reason for its decline in the market. And finally, did you know there was insurance for self-defense shootings and AI chatbot errors? In the Slate Plus episode: Can a (very expensive) calendar fix your marriage?  Want to hear that discussion and hear more Slate Money? Join Slate Plus to unlock weekly bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Slate Money show page on Apple Podcasts and Spotify. Or, visit slate.com/moneyplus to get access wherever you listen. Podcast production by Jessamine Molli and Cheyna Roth. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week: The stock market is coming back after its post Liberation Day fall. Felix Salmon, Emily Peck, and Elizabeth Spiers discuss what this does, and mostly doesn't, signal about the economy under Trump. Then, one stock that is not doing well at all is the UnitedHealth Group. The hosts explain the perfect storm the company has found itself in, and examine if that's actually the reason for its decline in the market. And finally, did you know there was insurance for self-defense shootings and AI chatbot errors? In the Slate Plus episode: Can a (very expensive) calendar fix your marriage?  Want to hear that discussion and hear more Slate Money? Join Slate Plus to unlock weekly bonus episodes. Plus, you'll access ad-free listening across all your favorite Slate podcasts. You can subscribe directly from the Slate Money show page on Apple Podcasts and Spotify. Or, visit slate.com/moneyplus to get access wherever you listen. Podcast production by Jessamine Molli and Cheyna Roth. Learn more about your ad choices. Visit megaphone.fm/adchoices

 We kick off with the latest developments in U.S.–China trade talks. The government just cut tariffs by 115%, effectively returning us to the original 30% rate where this economic game of chicken began. Is this The Art of the Deal in action—persistence, bluffing, and pushing boundaries to secure favorable “deals”? Next, AMC is trying to lure movie buffs back to theaters with half-price tickets on Wednesdays—just in time for the summer blockbuster season. We dive into the state of the cinema industry, how box office performance stacks up against broader consumer spending trends, and whether COVID has permanently changed how we watch movies. After the break, we explore the question: Does the energy demand of AI make electric utilities a potential investment play? One investor wonders if AI is a boon for individual electric companies—or if the better move is gaining exposure through a sector fund or ETF. Circling back to Trump-style deals, we examine what Republicans are proposing for the 2025 tax package—including a tax exemption for tipped income, an income tax carve-out for overtime pay, and a potential increase in the SALT deduction. To wrap up, we tackle the persistent lack of transparency in medical billing—particularly timely as UnitedHealth Group faces a federal investigation into Medicare fraud. Join hosts Nick Antonucci, CVA, CEPA, Director of Research, and Managing Associates K.C. Smith, CFP®, CEPA, and D.J. Barker, CWS®, and Kelly-Lynne Scalice, a seasoned communicator and host, on Henssler Money Talks as they explore key financial strategies to help investors navigate market uncertainty. Henssler Money Talks — May 17, 2025  |  Season 39, Episode 20 Timestamps and Chapters 5:49: Art of the Trade Deal 15:58: AMC's Curtain Call 32:35: AI's Power Play 39:13: Tax Free Tips 45:53: The Cost of Care Follow Henssler:  Facebook: https://www.facebook.com/HensslerFinancial/ YouTube:  https://www.youtube.com/c/HensslerFinancial LinkedIn: https://www.linkedin.com/company/henssler-financial/ Instagram: https://www.instagram.com/hensslerfinancial/ TikTok: https://www.tiktok.com/@hensslerfinancial?lang=en X: https://www.x.com/hensslergroup  “Henssler Money Talks” is brought to you by Henssler Financial. Sign up for the Money Talks Newsletter: https://www.henssler.com/newsletters/ 

Episode 584: Neal and Toby recap Walmart's Q1 earnings and how tariffs will likely cause price hikes. Then, Dick's Sporting Goods acquires Foot Locker for a massive $2.4B that may open the door into international markets. Meanwhile, the Dog of the Week is UnitedHealth Group and the Stock of the Week is Coinbase. Also, Harvard has been unknowingly sitting on top of an original Magna Carta when it thought it was a copy…this whole time!  Subscribe to Morning Brew Daily for more of the news you need to start your day. Share the show with a friend, and leave us a review on your favorite podcast app. Visit endthecampaign.com for more Listen to Morning Brew Daily Here: https://www.swap.fm/l/mbd-note  Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow 00:00 - Apple Vision Pro on Price is Right  03:15 - Walmart Price Hikes  07:40 - Dick's Purchases Foot Locker  11:00 - SOW: Coinbase  15:45 - DOW: UnitedHealth Group  19:00 - Magna Carta at Harvard  22:00 - Headlines  Learn more about your ad choices. Visit megaphone.fm/adchoices

Plus: The Justice Department is investigating UnitedHealth Group for possible Medicare fraud. And Dick's Sporting Goods nears a deal to buy Foot Locker for roughly $2.3 billion. Kate Bullivant hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Plus: Apple shares edge down after President Trump scolds CEO Tim Cook. UnitedHealth Group shares fall on WSJ report of Medicare fraud investigation. Foot Locker's stock soars on deal with Dick's Sporting Goods. Ariana Aspuru hosts. Sign up for the WSJ's free What's News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

US equity futures are weaker. European equity markets are lower in early trade, while most Asian markets ended in negative territory. No major developments on the US-China tariff front, though recent signs of de-escalation persist. USTR Greer is in South Korea for APEC meetings with ongoing negotiations across Asia. Meanwhile, April's CPI surprise earlier this week reduced expectations for rate cuts, with the market now pricing in less than 50 bp of easing this year. The White House hinted a new trade deal could be announced upon Trump's return, while Japan and South Korea deals are reportedly nearing completion. Attention also on geopolitical headlines including Iran's openness to a nuclear deal with the US and Russia's absence from the Ukraine peace talks in Istanbul.Companies mentioned: Dick's Sporting Goods, Foot Locker, UnitedHealth Group, Nvidia

Chuck Zodda and Mike Armstrong discuss Walmart's earnings coming in better than expected but warn customers that price increases are coming. How much pricing power do US companies actually have? Walmart is preparing to welcome its next customer: AI shopping agents. UnitedHealth Group is under criminal investigation for possible Medicare fraud. Why are so many couples having pets instead of children?

The White House unveiled what it says is $600bn worth of defence and artificial intelligence deals with Saudi Arabia, UnitedHealth Group shares sink to the lowest level in more than four years, and US inflation fell to 2.3 per cent in April. Plus, Nissan plans to axe 15 per cent of its global workforce and almost halve its number of plants.Mentioned in this podcast:Donald Trump lauds Saudi Arabia as he unveils AI and defence dealsUnitedHealth chief Andrew Witty steps down as shares plungeUS inflation falls to 2.3% in April as tariff effect loomsNissan to axe 15% of global workforce and almost halve number of plantsToday's FT News Briefing was produced by Sonja Hutson, Kasia Broussalian, Lulu Smyth, and Marc Filippino. Additional help from Simon Panayi, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT's co-head of audio. The show's theme song is by Metaphor Music.Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

In this episode, Scott Becker discusses UnitedHealth Group's sharp 16% stock decline following the surprise resignation of CEO Andrew Witty, raising concerns about the company’s future amid ongoing market volatility.

In this episode, Scott Becker discusses UnitedHealth Group's sharp 16% stock decline following the surprise resignation of CEO Andrew Witty, raising concerns about the company's future amid ongoing market volatility.

President Donald Trump secured a $600 billion commitment from Saudi Arabia on Tuesday to invest in the United States after the oil power accorded him a gala welcome at the start of a tour of Gulf states. The U.S. agreed to sell Saudi Arabia an arms package worth nearly $142 billion, according to a White House fact sheet that called it "the largest defense cooperation agreement" Washington has ever done.The U.S. annual inflation rate eased to its lowest level in more than four years, as President Donald Trump's tariffs started stretching throughout the U.S. economy. According to the Bureau of Labor Statistics (BLS), the annual inflation rate declined to 2.3 percent in April, from 2.4 percent in March. This represented the third consecutive monthly slowdown and the lowest reading since February 2021.UnitedHealth Group on Tuesday suspended its 2025 forecast, just weeks after lowering its outlook, and announced the surprise exit of CEO Andrew Witty, sending its shares down 8 percent premarket. Stephen Hemsley, who served as CEO from 2006–2017, will take over from Witty. The announcement also pulled down shares of other health insurers such as Humana, CVS, and Elevance between 1 percent and 3 percent.

Generative AI chatbots have changed the way people search online, making SEO tactics less effective. WSJ's CMO Today reporter Patrick Coffee explains how marketers are changing up their work. Plus, UnitedHealth Group says it has over 1,000 uses for AI. Enterprise tech reporter Isabelle Bousquette says that includes processing insurance claims, and the company is treading carefully. Julie Chang hosts. Sign up for the WSJ's free Technology newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

A leaked document shows the extent of proposed cuts coming to the Department of Health and Human Services. UnitedHealth Group had its worst day on the market in decade after it announced disappointing first quarter results. And, Cone Health has purchased Novant Health's ownership interest in their joint Medicare Advantage business. We get those stories and more coming up on today's episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Scott Becker covers eight key stories, including UnitedHealth Group's steep stock drop, President Trump's clash with Fed Chair Powell, and more.

In this episode, Scott Becker discusses UnitedHealth Group's unexpected 20% stock plunge following a major earnings miss, and its ripple effect on the Dow.

Nvidia CEO Jensen Huang is in Beijing, just as U.S. officials are eyeing his company's supply of AI chips to DeepSeek. CNBC's Kristina Partsinevelos explains the line between maintaining competition and preserving national security when it comes to tech infrastructure. Federal Reserve chair Jay Powell expressed concern that the central bank could be caught between controlling inflation and supporting economic growth, as tariffs contribute to economic uncertainty. President Trump responded, calling for a rate cut and the termination of Jay Powell as chair. Plus, the IRS is attempting to rescind Harvard's tax-exempt status, and shares of UnitedHealth Group plunged after the company cut its profit forecast. Kristina Partsinevelos - 26:40Peter Kraus - 31:43 In this episode:Kristina Partsinevelos, @KristinaPartsKelly Evans, @KellyCNBCJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinCameron Costa, @CameronCostaNY